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CardiomyocytesSorcin is a penta-EF-hand protein that interacts with intracellular target proteins after Ca2+ binding. The
sarcolemmal Na+/Ca2+ exchanger (NCX1) may be an important sorcin target in cardiac muscle. In this
study, RNAi knockdown of sorcin, purified sorcin or sorcin variants was employed in parallel measurements
of: (i) NCX activity in isolated rabbit cardiomyocytes using electrophysiological techniques and (ii) sorcin
binding to the NCX1 calcium binding domains (CBD1 and (iii) using surface plasmon resonance and gel
overlay techniques. Sorcin is activated by Ca2+ binding to the EF3 and EF2 regions, which are connected by
the D helix. To investigate the importance of this region in the interaction with NCX1, three variants were
examined: W105G and W99G, mutated respectively near EF3 and EF2, and E124A that does not bind Ca2+
due to a mutation at EF3. Downregulation of sorcin decreased and supplementation with wt sorcin (3 μM)
increased NCX activity in isolated cardiomyocytes. The relative stimulatory effects of the sorcin variants
were: W105GNwt sorcinNSorcin Calcium Binding Domain (SCBD)NW99GNE124A. Sorcin binding to both
CBD1 and 2 was observed. In the presence of 50 µM Ca2+, the interaction with CBD1 followed the order
W105GNSCBDNwt sorcinNW99GNE124A. In sorcin, the interacting surface can be mapped on the C-
terminal Ca2+-binding domain in the D helix region comprising W99. The fast association/dissociation rates
that characterize the interaction of sorcin with CBD1 and 2 may permit complex formation/dissociation
during an excitation/contraction cycle.+39 064440062.
mparelli).
NC-ND license. © 2010 Elsevier Ltd.Open access under CC BY-NC-ND license. 1. Introduction
Sorcin (soluble resistance-related calcium binding protein) is a
21.6 kDa protein identified in the cytosol of multidrug resistant cells
[1,2] that belongs to the penta-EF-hand (PEF) family, a small group of
regulatory calcium binding proteins comprising calpain, ALG-2,
grancalcin, peflin and PEF1 [3–8]. Sorcin shares the typical structural
and functional features of all PEF family members. It has a two-
domain architecture, characterized by a flexible and hydrophobic Gly/
Pro-rich N-terminal domain and a C-terminal calcium binding domain
containing the five EF-handmotifs (Fig. 1), and dimerizes through the
unpaired EF5 hand. Like the other PEF proteins, sorcin undergoes a Ca2+-
dependent activation that promotes translocation to membranes where
interaction with several molecular targets occurs [9]. In turn, these
features render sorcin an effective participant in a number of Ca2+-
mediated processes. Sorcin activation is induced by Ca2+ binding to thetwo functionally relevant EF3 and EF2 motifs, that are not paired
structurally as in most EF-hand proteins, but are connected by the long
and rigid D helix (Fig. 1). An essential step of sorcin activation therefore
consists in the transfer of information concerning Ca2+ binding from the
sitewith the highest affinity for themetal, EF3, through theDhelix to EF2,
and from there to the rest of the molecule. The ensuing conformational
change is believed to loosen the hydrophobic andhydrophilic interactions
that bring the N- and C-terminal domains together. This renders both
domains available for target protein recognition, in particular the D helix
residues [10]. It follows that the EF3-D helix-EF2 region should be
considered as a tightly coupled functional unit.
Sorcin is expressed in most human tissues including the heart
where Ca2+-bound sorcin interacts with and regulates several ionic
channels, such as the L-type voltage-dependent channel, the
ryanodine receptor, RyR2, and the sarcoplasmic reticulum Ca2+-
ATPase, SERCA2a, and thus plays an important role in the regulation of
the excitation–contraction–relaxation processes [11–18]. Discordant
effects of sorcin overexpression on cardiac function have been
reported. According to Seidler et al. [13] and Meyers et al. [19]
cardiac-specific overexpression of sorcin in rabbit myocytes and
transgenic mice leads to a significant reduction in contractility, while
Fig. 1. Sequence of Chinese hamster sorcin and structure of the Ca2+-binding domain, SCBD. (A) The amino acids of the N-terminal domain and of SCBD, involved in the interdomain
contact according to Ilari et al. [10], are in boldface. The residues mutated in the variants used (W99, W105, F112 and E124) are underlined. (B) left panel. The two monomers in the
SCBD dimer are depicted in different colours (light blue, gray). The D helix and the physiologically relevant EF2 and EF3 hands are coloured dark blue; the two tryptophan residues,
W99 and W105, are coloured red, Phe112 and Glu124 belonging to EF3 are coloured green. (B) right panel. The gray SCBD monomer is rotated 90° with respect to the dimer
presented on the left. The figure was created with PYMOL [42].
Fig. 2. Model of NCX1, according to Hilge et al. [24]. Structural details are given in the
Introduction. CBD1 in red and CBD2 in magenta.
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or mouse heart or isolated cardiac cells with sorcin-expressing vectors
significantly enhanced cardiac function.
The overexpression of sorcin in cardiomyocytes has also been
associated with increased activity of the Na+–Ca2+ exchanger, NCX
[13,22]. The mammalian NCX family includes three genes (Ncx1, Ncx2
and Ncx3) with very similar functional properties. NCX1, the main
isoform expressed in the heart, catalyzes the electrogenic exchange of
Ca2+ and Na+ across the plasma membrane in both the Ca2+ influx
and Ca2+ efflux mode and is one of the crucial regulators of Ca2+
homeostasis within cardiomyocytes and of cardiac contractility. NCX1
consists of nine transmembrane helices with an extracellular N-
terminus and a cytosolic C-terminus that is organized in four domains
[23,24]. There are two adjacent homologous Ca2+-binding domains,
CBD1 and CBD2, arranged in an antiparallel fashion, that are
connected via a regulatory catenin-like domain (CLD) to the
membrane part of the exchanger (Fig. 2). A rise in cytosolic Na+
stimulates rapidly and then inactivates the exchanger; in contrast,
cytosolic Ca2+ activates the exchanger and relieves the Na+-
dependent inactivation [25–28]. Regulation by cytosolic Na+ and
Ca2+ involves sites that do not participate directly in the ion
translocation process. Thus, an amphipathic sequence, the XIP region
(eXchanger Inhibitory Peptide), takes part in regulation by Na+,
whereas CBD1 and CBD2 are responsible for the Ca2+-dependent
activation of the exchanger. Both CBD1 and CBD2 have an Ig-like fold
with the Ca2+-binding sites in the distal loops [24,28,29]. They
contain also an unstructured loop, the FG loop, which in CBD2 is
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region (Fig. 2). Despite the structural similarity, CBD1 binds four Ca2+
with high affinity (KD=0.3 μM), whereas CBD2 binds only two metal
ions with lower affinity (KD=5 μM) [30]. In CBD1, the four Ca2+ ions
are brought into close proximity by a complex arrangement of the
coordinating residues. Thus, aspartate and glutamate carboxylate
oxygens provide bidentate ligands that coordinate two (Asp500) or
three (Glu451) Ca2+ simultaneously. In CBD2, the two Ca2+-binding
sites are only 5.4 Å apart, such that the twometal ions are coordinated
by two carboxylate oxygens of a single aspartate side chain (Asp578).
Mutations of acidic Ca2+-binding amino acid residues in CBD1
decrease affinity for Ca2+, as expected, but do not eliminate Ca2+-
dependent regulation [26]. In contrast, mutations E516L, D578V and
E648L in the CBD2 Ca2+-binding sites completely remove Ca2+
regulation, placing the exchanger in a constitutionally active state
[28]. In accord with these observations, the alternatively spliced NCX1
kidney isoform with an arginine at position 578 and the brain isoform
carrying a D578R mutation are not regulated by Ca2+ [31]. Taken
together these data point to CBD1 and CBD2 as major determinants of
the NCX1 functional regulation.
Several experimental data point to an effect of sorcin on NCX
function in the heart, indicative of a possible direct interaction
between the two proteins. In particular, NCX activity is increased in
sorcin-overexpressing cardiomyocytes, while a low NCX activity has
been observed in a rabbit model of left ventricular dysfunction (LVD)
with a reduced sorcin expression level [13,22].
In the present work, the study of the sorcin-NCX1 system was
investigated by parallel experiments on the isolated components and
on cardiomyocytes. Overlay assay and surface plasmon resonance
(SPR) experiments allowed us to establish the occurrence of a direct
interaction between sorcin and the two NCX1 calcium binding
domains and to characterize its kinetic and equilibrium parameters,
while measurements of the NCX current in cardiomyocytes as a
function of voltage furnished information on the functional effect of
the interaction. Further, the surface of the sorcin molecule involved in
complex formation was determined by means of previously charac-
terized sorcin variants carrying mutations at sites involved in Ca2+
binding or information transfer. The effects of the mutations on the
interaction parameters were assessed in surface plasmon resonance
experiments, while those on function were determined by means of
NCX current measurements. Specifically, the C-terminal, sorcin Ca2+-
binding domain (SCBD) was employed to establish whether this
domain is the interacting one [4,32]; the E124A mutant was used to
gain information on the Ca2+-dependence of the interaction since this
variant is unable to bind Ca2+ at physiological concentrations due to
substitution of the bidentate Ca2+ ligand at the EF3 hand [33]; the
W99G and W105G variants were utilized as selective probes of the
local structural perturbations introduced by substitution of the two
tryptophan residues located at the beginning and end of the D helix
[34].
The results obtained point to the Ca2+-dependent interaction
between sorcin and NCX1 as the basis for the activation of the
transporter. In sorcin, the interacting surface can be mapped on the
Ca2+-binding C-terminal domain in the region of the D helix
comprising W99. In NCX1, both CBD1 and CBD2 participate in
complex formation. Intriguingly, the rates of complex formation/
dissociation are fast and could permit a beat-to-beat interaction.2. Materials and methods
2.1. Cloning, expression and purification of sorcin and of sorcin mutants
Wild type human and Chinese hamster sorcin, SCBD (Sorcin
Calcium Binding Domain) and sorcin mutants were cloned, expressed
and purified as described previously [10,33,35].2.2. Cloning, expression and purification of CBD1 and CBD2
The cDNA of Mus musculus NCX1 (cDNA clone MGC:90693
IMAGE:30532156) was used as template in PCR experiments in
order to clone the nucleotide regions 1192–1619, encoding for CBD1
(Calcium Binding Domain 1), corresponding to amino acids 397–539,
and 1581–2137, encoding for CBD2 (Calcium Binding Domain 2),
corresponding to amino acids 527–712. The PCR products, digested
with NdeI and HindIII restriction enzymes, were cloned in the pET22
vector. The recombinant vectors were used to transform competent E.
coli BL21(DE3) cells. Protein expression was induced by 1 mM IPTG
for 5 h at 37 °C. After sonication (1 min at 14 Hz/mL cell solution), the
lysates were centrifuged at 15,000 rpm for 20 min: CBD1 was
recovered in the supernatant, whereas CBD2 remained in the
insoluble fraction. CBD1 purification was carried out by 30% (w/v)
ammonium sulphate precipitation at room temperature for 1 h, while
CBD2 purification required protein extraction by treatment with 0.3%
N-lauryl-sarcosine in 50 mMCAPS buffer pH 11.0. An anion exchanger
column Mono-Q (GE Healthcare) was used to improve purification of
both NCX1 domains. The proteins, dialysed vs. a 10 mM Tris–HCl
buffer at pH 7.5, were loaded onto the column and were recovered
upon application of a linear gradient of NaCl between 0 and 0.5 M.
Based on SDS page electrophoresis, the degree of enrichment was
∼80% for CBD1 and ∼70% for CBD2. In the SPR experiments the
concentration of CBD1 and CBD2 was calculated from the intensity of
the respective bands in SDS gels (Supplementary Fig. S1) after
determination of the total protein concentration with the Bradford
assay.
2.3. Overlay assay experiments
Wt sorcin and SCBD were subjected to electrophoresis on a 15%
polyacrylamide gel under denaturing conditions [36] and transferred
to polyvinyl difluoride membranes (PVDF) in transfer buffer [25 mM
Tris–HCl, 192 mM glycine, and 20% methanol (pH 8.3)] at 100 mA for
45 min. The PVDF membranes were incubated at room temperature
separately with CBD1 and CBD2 (20 µg/mL) in 1% gelatin in TBST
buffer [20 mM Tris–HCl, 0.5 M NaCl, and 0.05% Tween 20 (pH 7.5)]
containing either 50 µM CaCl2 (total concentration) or 1 mM EGTA to
assess the calcium dependence of the interaction. Subsequently, the
membranes were incubated in 1% gelatin in TBST buffer with a mouse
anti-NCX1 monoclonal antibody (antigen: purified canine cardiac
NCX; Biocompare). The antibody was used at 1:3000 dilution, a
condition where it recognizes equally well CBD1 and CBD2 and does
not recognize other proteins like albumin and gelatin, as established
in preliminary experiments. The blots were developed by incubation
for 45 min with alkaline phosphatase conjugated monoclonal anti-
mouse IgG in 1% gelatin in TBST. Control experiments ruled out the
existence of cross reactivity between sorcin or SCBD and the anti-NCX
monoclonal antibody.
2.4. Surface plasmon resonance measurements
Surface plasmon resonance (SPR) experiments were carried out
using a BIACORE X system (BIAcore AB, Uppsala, Sweden). The sensor
chip (CM5, Biacore AB) was activated chemically by a 35 µL injection
of a 1:1 mixture of N-ethyl-N′-(3-(dimethylaminopropyl) carbodii-
mide (200 mM) and N-hydroxysuccinimide (50 mM) at a flow rate of
5 µL/min. In one set of experiments, sorcin was immobilized on the
activated sensor chip via amine coupling. The reaction was carried out
in 20 mM sodium acetate at pH 6.0; the remaining ester groups were
blocked by injecting 1 M ethanolamine hydrochloride (35 µL). This
procedure ensures immobilization of sorcin principally via the N-
terminus [32]. As a control, the sensor chip was treated as described
above in the absence of sorcin. The interaction of immobilized sorcin
with the CBD1 and CBD2 domains of NCX1was detected throughmass
135C. Zamparelli et al. / Journal of Molecular and Cellular Cardiology 49 (2010) 132–141concentration-dependent changes in the refractive index on the
sensor chip surface expressed as resonance units (RU). The increase in
RU relative to baseline indicates complex formation; the plateau
region represents the steady-state phase of the interaction, whereas
the decrease in RU represents dissociation of the NCX1 calcium
binding domains from immobilized sorcin after injection of buffer. A
response change of 1000 RU typically corresponds to a change in the
protein concentration on the sensor chip of 1 ng/mm2 [37]. The
experiments were carried out at 25 °C in 10 mM HEPES (pH 7.4),
150 mMNaCl, and 0.005% surfactant P-20. The buffer was treatedwith
Chelex 100 to eliminate Ca2+ contaminations and degassed. The
concentration of CBD1 and CBD2 ranged between 500 nM and 22 µM
at a constant calcium concentration.
In a second set of experiments, CBD1 was immobilized on the
activated CM5 chip at pH 4.5 using the procedure described above.
The interaction with wt sorcin or sorcin mutants (E124A, W99G,
W105G and SCBD) at a concentration of 1 µM was measured in the
presence of 20 and 50 µM Ca2+. Scatchard analysis of the dependence
of the SPR signal at steady state (Req) on the concentration of CBD1
and CBD2 was performed to determine the equilibrium dissociation
constant. Req values were calculated from the sensorgrams using
BIAevaluation version 3.0. The amine coupling kit, the P-20 surfactant,
and the CM-5 sensor chip were purchased from BIAcore AB and all the
other reagents were high-purity grade.
Negative controls for the SPR experiments were obtained by
transformation of E. coli BL21(DE3) with pET22, induction with 1 mM
IPTG for 5 h at 37 °C, and subsequent sonication and centrifugation;
the supernatants were treated as for the CBD1 and CBD2 preparations,
but the last purification step by anion exchanger chromatography was
omitted (Supplementary Fig. S1).
2.5. Measurement of NCX currents in isolated cardiac myocytes
Procedures were undertaken in accordance with the United
Kingdom Animals (Scientific Procedures) Act 1986 and conform to
the Guide for the Care and Use of Laboratory Animals published by the
US National Institutes of Health (NIH Publication No. 85-23, revised
1985). New Zealand White male rabbits were given an intravenous
injection of 500 U heparin together with an overdose of sodium
pentobarbitone (100 mg/kg) and their hearts were removed. Isolated
hearts were perfused retrogradely (25 mL min−1, 37 °C) with
a nominally Ca2+-free Krebs–Henseleit solution containing
0.6 mg mL−1 collagenase (type 1, Worthington Chemical Co) and
0.1 mg mL−1 protease (type XIV, Sigma Chemical Co) for 6–8 min.
After isolation of the left ventricular free wall, the epicardial layers of
the free wall were isolated from the remaining tissue by dissecting a
1–1.5 mm layer from the epicardial surface. The layers of tissue were
incubated separately for 5 min in enzyme solution containing
80 μmol/L CaCl2 and 4% bovine serum albumin (BSA, fraction V,
Sigma). The cardiomyocyte suspensions were obtained at the end of
the incubation period. Isolated cardiomyocytes were superfused with
a HEPES-based Tyrode's solution at 36–37 °C in a chamber mounted
on the stage of an inverted microscope. Voltage clamp was achieved a
using an Axoclamp 2A amplifier (Axon Instruments, Foster City, CA,
USA) in discontinuous (switch clamp) mode. Pipette resistance was
1–2 MΩ. The Tyrode's solution superfusing isolated cells contained
(mmol/L): NaCl (140), KCl (4), HEPES (5), MgCl2 (1), CaCl2 (1.8), and
glucose (11.1), pH 7.4 with NaOH. The perfusate also contained
strophanthidin (0.01 mmol/L) and nifedipine (0.01 mmol/L), 4-
aminopyridine (5 mmol/L, to block K+ currents) and niflumic
acid (0.1 mmol/L, to block Ca2+-activated Cl− currents. The pipette
solution contained (mmol/L): CsCl (45), EGTA/CaEGTA (Cs+
100, EGTA 50, Ca2+ 25), HEPES (20), MgCl2 (11, calculated free
Mg2+≈1.2 mmol/L), and Na2ATP (10); pH 7.25. This pipette
solution was designed to buffer [Ca2+]i to ∼250 nmol/L (confirmed
by separate [Ca2+] measurements). After achieving the whole-cellconfiguration, a period of 5–10min was allowed for dialysis of the
pipette solution into the cell. Currents were then measured in
response to a 3 s ramp from −120 mV to +80 mV from the holding
potential of −80 mV. An ascending ramp was chosen since this has
been shown to cause less perturbation of sub-sarcolemmal [Ca2+]
than a descending ramp, and the resulting currents are closer to those
obtained using a voltage step protocol [38]. The ramp protocol was
performed at 0.1 Hz, when steady-state currents were achieved; data
from 12 ramps were recorded for subsequent averaging. The protocol
was repeated in the presence of 5 mmol/L Ni2+ to obtain the
background current, and this was subtracted to obtain the current
attributable to NCX (see Fig. 3(A)). Sorcin or themutant proteins were
added to the intracellular pipette solution for dialysis into the cell at a
concentration of 3 μM using a protocol similar to previous work,
designed to supplement endogenous intracellular sorcin by compa-
rable amounts of exogenous protein [15,16]. Allowing sorcin to dialyse
into the cell for 10 to 20 min had no additional effects (data not
shown). Preliminary experiments using 1 μM sorcin had no significant
effect on the NCX current (see Supplementary Fig. S5). Control
measurements were made by adding identical amounts of the
suspension buffer. The control and experimental data were always
obtained on the same experimental day.
2.6. Preparation and testing of sorcin RNAi virus
As previously described [16], a partial rabbit sorcin sequence was
amplified using primers based on the known human sorcin sequence
by reverse transcription of RNA from a chinchilla bastard rabbit. Sense
and antisense oligonucleotides were chosen to target the 19
nucleotide segment complementary to the rabbit sorcin mRNA
sequence GCAAGAUCACCUUCGAUGA and ligated downstream of a
U6 promoter into vector pSIREN-DNR (BD Biosciences Clontec, Palo
Alto, USA). Six different siRNA sequences were cloned into pSIREN
and verified for their effectiveness in a rabbit tumor cell line VX2.
Knockdown was verified via RT-PCR. The most effective siRNA was
selected to generate recombinant adenovirus. Recombination with
the remaining adenoviral genome using pAdeno-X vector was carried
out according to the manufacturer's instructions (BD Adeno-X
Expression System, BD, Biosciences Clontech, Palo Alto, USA).
Infection of adult ventricular cardiomyocytes with the AdRNAi virus
(100 MOI) resulted in downregulation of native sorcin expression to
27±7% of control value after 36h of quiescent culture [16]. Example
blots demonstrating of downregulation of sorcin RNA and protein are
shown in the online supplement (Supplementary Fig. S5).
3. Results
3.1. Sorcin modulates NCX activity in isolated rabbit cardiomyocytes
Fig. 3(A) demonstrates the protocol used to extract the membrane
current associated with NCX. Previous studies have shown that the
current–voltage relationship of the Ni2+-sensitive current corre-
sponds well to the predicted relationship for NCX [39]. Specific
downregulation of native sorcin protein levels to b30% of control
values resulted in a significant decrease in NCX activity across the
voltage range (Fig. 3(B)) to approximately 50% of the control level.
This suggests that native sorcin levels tonically stimulate NCX under
control levels. In separate experiments, inclusion of 3 μMwt sorcin in
the pipette to supplement intracellular sorcin levels resulted in a
dramatic increase in NCX activity (Fig. 3(C)).
3.2. Sorcin and NCX1 interact directly by means of the respective Ca2+-
binding domains: overlay assay experiments
The immunoblot experiments presented in Fig. 4 show that sorcin
interacts with NCX1 by means of SCBD and that the interaction
Fig. 3. Effect of sorcin and knockdown of sorcin on cardiac NCX activity. (A) The ascending voltage ramp protocol (−120 to +80 mV in 3 s) applied to a single ventricular
cardiomyocyte and the associated membrane currents in the absence and presence of 5 mmol/L Ni2+ (the zero current level indicated by the horizontal line). The Ni2+-sensitive
signal (lower panel) represents the current carried by NCX (INCX). This protocol was used to generate the average I–V relationships shown in (A(ii)) for normal cardiomyocytes
(n=20 cells from 3 hearts). (B) shows the data from cardiomyocytes transfected with mRNAi virus for sorcin compared to the Ad-LacZ control. The relative change in currents at
−120 mV and+80 mV are shown in (B(ii)). INCX is lower in myocytes transfected with the mRNAi adenovirus that reduces sorcin expression. (*Pb0.05, n=15 cells from 3 hearts in
both groups). (C) shows the I–V curve recorded from cells with 3 µM sorcin dialysed into the cell via the intracellular pipette. INCX was significantly increased in cardiomyocytes
compared to control (n=15 myocytes from 3 hearts in each group).
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NCX1 domains appear to interact with sorcin in a similar manner.
When incubation is carried out in the presence of EGTA no bands are
visible in the immunoblot (Supplementary Fig. S3), an indication that
complex formation is specific and calcium dependent.
3.3. SPR characterization of the sorcin–NCX1 interaction
Surface plasmon resonance experiments were performed to
characterize the binding reaction quantitatively. In a first series of
experiments, sorcin was immobilized onto the chip. The changes inrefractive index (RU) that occur during injection of the CBD1 and
CBD2 solutions at different concentrations in the presence of 50 μM
CaCl2 are depicted in Figs. 5(A), (B) and the Scatchard analysis of the
data is presented in Fig. 5(C). The equilibrium and kinetic parameters
that describe the interaction of immobilized sorcin with the two NCX1
domains are rather similar. In particular, the equilibrium dissociation
constant pertaining to CBD1 and CBD2 correspond to KD=7±2 μM
and 3±1.7 μM, respectively. As expected, the interaction with both
CBD1 and CBD2 depends on calcium concentration. At nanomolar
calcium (a concentration achieved by addition of 2 mM EDTA) no
interaction takes place as shown by the extremely small Req values
Fig. 4. Interaction of CBD1 and CBD2 with wild type sorcin and SCBD. Sorcin and SCBD
(20 µg) were subjected to electrophoresis under denaturing conditions and transferred
to PVDF membranes. These were incubated at room temperature with CBD1 (panel A)
and CBD2 (panel B) in the presence of 50 μM CaCl2 and subsequently with an anti-NCX
monoclonal antibody. The blots were developed by incubation with alkaline
phosphatase conjugated monoclonal anti-mouse IgG. Lane 1: molecular markers (46,
30, 21.5, and 14.3 kDa); lane 2: sorcin; lane 3: SCBD. The arrow indicates the molecular
weight corresponding to sorcin.
Fig. 5. SPR measurement of the interaction between immobilized wild type sorcin and
the NCX1 Ca2+-binding domains, CBD1 and CBD2, at different protein concentrations.
The increase in RU relative to baseline indicates complex formation; the plateau region
represents the steady-state phase of the interaction, whereas the decrease in RU
represents dissociation of CBD1 and CBD2 from immobilized sorcin after injection of
buffer. The buffer was 10 mMHEPES, 0.15 M NaCl, and 0.005% surfactant P-20 (pH 7.4),
containing 50 μM CaCl2. The temperature was 25 °C. The sensorgrams shown are the
average of two experiments. (A) CBD1 injected at protein concentrations of 0.45, 1.8,
4.5, 9, 18, 27, and 35 μM, from bottom to top. (B) CBD2 injected at protein
concentrations of 0.50, 1.1, 4.5, 10, and 22 μM, from bottom to top. (C) Scatchard
plot: the plateau signal at steady state (Req) measured at different CBD1 and CBD2
concentrations is plotted as a function of Req/C. CBD1: Δ, CBD2: □.
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time courses are alike. Experiments with negative control prepara-
tions ruled out the occurrence of aspecific binding (Supplementary
Fig. S4).
In another set of experiments CBD1 and CBD2 were immobilized
on the sensor chip and their interaction with soluble wt sorcin was
measured. For CBD1, the results obtained at 50 μM Ca2+ yield an
equilibrium constant KD=1.2±2 μM, while CBD2 interacts with
sorcin with an equilibrium constant KD=1.0±2 μM, in satisfactory
agreement with the data obtained with immobilized sorcin. The
increase in RU at nanomolar Ca2+ concentration was negligible.
These observations prompted the experiment depicted in Fig. 6
aimed at mimicking the changes in Ca2+ concentration that occur
during an excitation–contraction–relaxation cycle. Thus, wt sorcin
was bound to immobilized CBD1 at 50 μMCa2+ andwas dissociated at
nM Ca2+ (i.e. in the presence of 2 mM EDTA). The sorcin–CBD1
complex dissociates about ten-fold faster (kd=0.9±0.4 s−1) than at
50 μM Ca2+. The parallel experiment at the latter Ca2+ concentration
is also shown to allow a direct comparison. Similarly, wt sorcin was
bound to immobilized CBD2 at 50 μM Ca2+ and was dissociated at nM
Ca2+. At this Ca2+ concentration the sorcin–CBD2 complex dissociates
about ten-fold faster (kd=0.6±0.2 s−1) than at 50 μM Ca2+ just like
the sorcin–CBD1 one.
The SPR results are compiled in Table 1.
3.4. Effect of sorcin mutants on NCX1 activity
The presence of 3 μM sorcin Ca2+-binding domain (SCBD)
increases NCX activity by about 120% relative to control suggesting
this domain is important in the stimulation of NCX1 activity, in accord
with its involvement in formation of the sorcin–NCX1 complex
(Fig. 7). The different sorcin variants analyzed have strikingly
different effects on the activity of NCX1 as already observed in the
case of the Ca2+ spark properties which reflect RyR2 activity in
cardiomyocytes [33,34]. This applies in particular to the W99G and
W105G variants which carry a mutation in the D helix at a distance ofonly two helical turns. The W105G variant quadruplicates NCX
activity with respect to control and therefore resembles wt sorcin
(Fig. 3), whereas W99G increases the Ni2+-sensitive currents by
about 60% with respect to control. The E124A mutant, characterized
by impaired binding of Ca2+ to the highest affinity EF3 site, is
indistinguishable from control.
Fig. 6. SPR measurement of the interaction between wild type sorcin and immobilized CBD1 (A) and with immobilized CBD2 (B). Sorcin concentration was 6 μM in 10 mM HEPES,
0.15 M NaCl, and 0.005% surfactant P-20 (pH 7.4), containing 50 μM CaCl2. The temperature was 25 °C. The increase in RU relative to baseline indicates complex formation in the
presence of 50 μM CaCl2, whereas the decrease in RU represents dissociation of sorcin from CBD1 after injection of buffer containing 50 μM CaCl2 (solid line) or 2 mM EDTA (dashed
line). The panel on the right shows the beginning of the dissociation phase. The sensorgrams are the average of two experiments.
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The NCX activity data just presented were supplemented by SPR
experiments in which the interaction between immobilized CBD1 and
soluble wt sorcin or sorcin variants at the same protein concentration
was monitored (Fig. 8). In the presence of 50 µM Ca2+, the interaction
with CBD1 follows the order W105GNSCBDNwt sorcinNW99G based
on the observed increase in RU. The corresponding KD values decrease
from 26 to 2.0 μM (average of two experiments). In case of the E124A
variant the increase in RU was negligible.
4. Discussion
The current study demonstrates a tonic influence of sorcin on NCX;
downregulation of sorcin levels decreases NCX activity and addition of
wt sorcin stimulates NCX. The study also provides evidence for aTable 1
Equilibrium and kinetic constants for the sorcin–NCX domains interaction as assessed from
KD (M)
50 µM CaCl2
Immobilized-soluble protein
Sorcin–CBD1 7×10−6±2×10−6
Sorcin–CBD2 3×10−6±1.7×10−6
CBD1–sorcin 1.2×10−6±2×10−6
CBD2–sorcin 1.0×10−6±2×10−6
Conditions: 10 mM HEPES (pH 7.4), 150 mM NaCl, and 0.005% surfactant P-20, in the presedirect interaction between sorcin and NCX1 and thus furnishes a
molecular explanation for the activation of the exchanger associated
with increased expression of sorcin in cardiomyocytes [13,22].
A dual experimental approach was used to advantage. Overlay and
SPR measurements on the isolated proteins/domains allowed the
kinetic and equilibrium characterization of the interaction with NCX1
subfragments while NCX activity measurements on cardiomyocytes
were used to extend the conclusions thus drawn to a cellular context.
In the case of sorcin, the behaviour of the wild type protein was
compared to that of the Ca2+-binding domain, SCBD, and of the site-
specific mutants used successfully to map the surface interacting with
RyR2 [34]. As far asNCX1 is concerned, the twomajor cytoplasmicCa2+-
binding domains, CBD1 and CBD2, were chosen in view of their
important regulatory role. The choice of these NCX1 domains proved to
be correct based on the agreement of the NCX activity results and those
of the overlay experiments (Figs. 3 and 4). Thus, sorcin increases NCXSPR experiments.
ka (M−1 s−1) kd (s−1) kd (s−1)
50 µM CaCl2 50 µM CaCl2 2 mM EDTA
4×104±1×104 0.27±0.1
8×104±3×104 0.24±0.1
7×104±4×104 0.08±0.1 0.9±0.4
5×104±4×104 0.05±0.03 0.6±0.2
nce of 50 µM CaCl2. Temperature 25 °C.
Fig. 7. Effect of sorcin variants on NCX activity. (A) shows the average Ni2+-sensitive current recorded from single cardiomyocytes with a series of sorcin variants dialysed into the
cell via the intracellular pipette: (i) SCBD; (ii) W105G (iii) W99G and (iv) E124A. (B) shows the relative change in INCX current at−120 and 80 mV. The variants have the following
relative potency: W105GNSCBDNW99GNE124A.
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interact with sorcin. Both types of data also show that sorcin interacts
with NCX1 via the C-terminal Ca2+-binding domain. The fact that SCBD
is indistinguishable from full-length sorcin in the overlay experiments,
but has a somewhat lower activating effect on the Ni2+-sensitive
current in cardiomyocytes in turn indicates that the N-terminal sorcin
domain may participate in the interaction.
The SPR analysis of the sorcin interaction with CBD1 and CBD2
confirms the involvement of both exchanger domains in complex
formation and shows that the respective equilibrium and kineticparameters are very similar. Thus, at a Ca2+ concentration of 50 µM,
the equilibrium dissociation constant between immobilized sorcin
and the two NCX1 domains is 3–7 µM resulting from an association
rate constant of 4–8×104 M−1 s−1 and a dissociation rate constant of
0.24–0.27 s−1 (Fig. 5). Importantly, comparable results are obtained
also in the reciprocal experiment, which entails the use of immobi-
lized CBD1 or CBD2 (Figs. 6 and 8), an indication that steric effects due
to immobilization have only a minor effect on the interaction. From a
cellular perspective more informative values are obtained when
association between CBD1 and sorcin takes place at 50 µM Ca2+ and
Fig. 8. Binding of wild type sorcin and sorcin variants to immobilized CBD1.
Concentration of wt sorcin and variants was 6 μM, in 10 mM HEPES, 0.15 M NaCl,
50 μM CaCl2, and 0.005% surfactant P-20, at pH 7.4. The increase in RU relative to
baseline indicates complex formation, whereas the decrease in RU represents
dissociation of sorcin from the immobilized CBD1 domain after injection of buffer.
The temperature was 25 °C. The sensorgrams shown are the average of two
experiments. From top to bottom: W105G, SCBD, wt sorcin, W99G, and E124A.
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mimic those occurring during the excitation–contraction–relaxation
cycle (Fig. 6). This experiment clearly shows that the decreased
affinity of the two proteins at nanomolar Ca2+ can be attributed to
the significant increase in the rate of dissociation of the complex
(kd=0.9±0.4 s−1, corresponding to t1/2 values of 0.5–1.4 s) upon
decrease in Ca2+ concentration.
Having established that sorcin and NCX1 interact via the
respective Ca2+-binding domains and having characterized the
interaction in thermodynamic and kinetic terms, the identification
of the interacting surface on the sorcin molecule was addressed. The
site-specific sorcin variants of EF3 hand and D helix residues used
previously to identify the sorcin region involved in complex formation
with RyR2 were employed [33,34]. These mutants revealed similar-
ities and differences in the sorcin–RyR2 and sorcin–NCX systems
which both involve the sorcin D helix. However, the complex with
NCX1 is formed via the sorcin region near EF3 comprising W99. Thus,
removal of W99 almost abolishes interaction with the exchanger
(Fig. 8) and its activation (Fig. 7), while mutation ofW105 leaves both
properties unaltered with respect to wt sorcin. In contrast, the
interaction with RyR2 is severely compromised when W105 is
mutated, but is affected only marginally upon substitution of W99
[34].
The data just presented shed light only on part of the events that
are triggered by Ca2+ binding to sorcin and NCX leading to an
increased NCX activity. The affinity for Ca2+ is such that at low
micromolar Ca2+ concentrations both proteins are saturated with Ca2+
[30,33] and acquire the conformation that renders them able to
interact with fast kinetics via the respective Ca2+-binding domains.
The sorcin Ca2+-binding domain participates also in the interaction
with RyR2, but not in the sorcin–annexin VII interaction which takes
place via the respective N-terminal regions [32–34]. In sorcin, the
beginning of the D helix within the EF2-D helix-EF3 functional unit is
a crucial spot for complex formation as indicated by the effect of the
available site-specific variants employed. No such detailed informa-
tion is available for the CBD1 and CBD2 domains, although it may be
hypothesized that sorcin binding to CBD2 favours a conformation
resembling that of its constitutionally active mutants [28]. If so, Ca2+-
binding sites such as E516, D578 and E648 of NCX1 could interact
directly with sorcin; such interaction could remove Ca2+ regulation,
placing the exchanger in a constitutionally active state [28]. The
alternative splicing sequence of CBD2, which forms the unstructured
FG loop and is accounted for being part of the regulation of NCX1[24,40] is not important for sorcin binding, since sorcin binds similarly
to CBD1 and the full-length CBD2 variant. The stoichiometry of the
interaction is likewise not known. The location of the D helices on
opposite sides of the sorcin dimer (Fig. 1) renders their concomitant
interaction with CBD1 and CBD2 in the spatial relationship proposed
by Hilge et al. [23,24] and depicted in Fig. 2 unlikely, despite the
flexibility of the loops involved. Complex formation between two
sorcin dimers and one NCX molecule cannot be excluded based on the
available data.
As mentioned above, the interaction of sorcin with CBD1 and CBD2
is characterized by fast kinetics, both in terms of on and off rates. Both
rates are fast enough to allow for a partial cycle of association with
(and activation of) NCX and dissociation from (deactivation of) NCX
within fractions of seconds and may allow NCX regulation on a “beat
to beat” basis. The Ca2+ sensitive modulation would act in addition to
the Ca2+ dependence associated with Ca2+ binding to the CBD1 and
CBD2 domains. The reasons for two parallel levels of Ca2+ dependant
regulation is unknown, but a similar principle appears to apply to the
regulation of L-type Ca2+ channel, RyR2 and SERCA i.e. modulation by
direct interaction of Ca2+ and indirectly via Ca2+-dependent sorcin
interaction. Further work is required to determine what aspect of cell
function is mediated by this parallel series of Ca2+-dependent
interactions.
In more general terms, NCX has an important role in Ca2+
homeostasis in a variety of tissues, such as the heart, the kidney and
the brain, and is a key player in pathological situations that involve
dysregulation of Ca2+ balance [41]. The calcium-dependent translo-
cation of sorcin to membranes, and its ability to interact with different
targets (in heart, brain and other tissues) and to alter their activity,
makes sorcin an efficient regulator of different functions in different
cell types. The activatory role of sorcin can be important in short-term
and long-term regulation of NCX1 and may have an impact in diverse
pathologieswhere NCX1 is involved. In heart cells, the effects of sorcin
on intracellular Ca2+ and contractility is difficult to predict, as it will
depend on the status of the target channels (L-type Ca2+ channel and
ryanodine receptor), pumps (sarcoplasmic reticulum Ca-ATPase) and
exchangers (NCX1). For instance the discrepancy between sorcin-
mediated decrease in intracellular Ca2+ reported in rabbit myocytes
[13] and sorcin-mediated decrease in intracellular Ca2+ reported in
rat myocardium [20,21] may be explained by the higher intracellular
Na+ in rat heart. Under these conditions, the capacity for Ca2+
extrusion is reduced and consequently the ability of sorcin to
stimulate Ca2+ efflux is limited. Therefore additional effects on L-
type, RyR or SR Ca2+-ATPasemay dominate and promote contractility.
Alternatively in rabbit, the low intracellular Na+ will ensure that NCX
extrudes Ca2+ during diastole; therefore, sorcin-mediated stimulation
of NCXwill lower intracellular Ca2+ and this effect may dominate over
the others in determining intracellular Ca2+ signals.Acknowledgments
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